A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease

Korábbi kezelés

• Patients who have taken aspirin within two weeks before randomization
• Patients who need antiplatelet or anticoagulant medication except Aspirin
• Those participating in other clinical trials for investigational products

Más betegség

• Patients who is scheduled surgery due to coronary artery disease or cerebral infarction disease.
• Patients with a history of cerebrovascular and cardiovascular complications (brain infarction, transient cerebral ischemic seizures, myocardial infarction, unstable angina, coronary artery bypass graft, percutaneous coronary artery intervention) within the last six months
• Patients with bleeding

Laborértékek

• Confirmed below results at screening
  • Hemoglobin <13g/dL
  • Platelet <60,000/µL
  • Severe kidney disease patient with eGFR(estimated Glomerular Filtration Rate) <30 mL/min/1.73 m2 (CKD-EPI)

Egyéb

• Pregnant or lactating women
• Patients deemed to be ineligible to participate in the trial by investigator

• Both man and woman who is over 19 years old
• Identified as 10-75% of Stenosis in Coronary Angiography or Coronary CTA(Coronary computed tomography angiography)
• Patients who diagnosed with peripheral artery disease or has symptoms
• Written informed consent